Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

The Next Frontier?  A.I., Big Data, And The Rise Of “Data Relators”  

Feb 9, 2024 | DOJ, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud

Recently, as I scrolled through my Google News Alert email for “False Claims Act,” one government press release caught my eye.  The title – “National Roofing Company Settles PPP Fraud Allegations for $9 Million” – while certainly noteworthy, was not what interested...

The Georgia Composite Medical Board Extends Tele-prescribing Flexibility until May 1

Feb 7, 2024 | Health Care

At Chilivis Grubman, we strive to keep you abreast of crucial developments in healthcare regulations. In December, we notified you of significant changes to telemedicine prescribing by the Georgia Composite Medical Board (the Board). The Ryan Haight Online Pharmacy...

Regulatory Affairs Specialist Will Spend 1 Year in Prison for Falsifying FDA Documents

Feb 1, 2024 | Health Care

The DOJ announced that Peter Stoll III, former employee of a medical device company located in Pennsylvania, will serve prison time for falsifying U.S. Food and Drug Administration (FDA) documents. Stoll was employed as a regulatory affairs specialist, and he was...

Former Department of Homeland Security Employees Sentenced for Conspiracy to Steal Proprietary U.S. Government Software and Databases

Feb 1, 2024 | White Collar Crime

On January 29, the Department of Justice announced three former Department of Homeland Security (DHS) employees were sentenced in the District of Columbia for their involvement in a conspiracy to steal proprietary software and sensitive law-enforcement databases from...

Oil Company to Pay Nearly $35 Million to Resolve Allegations of Violating the FCA

Jan 25, 2024 | False Claims Act

The DOJ announced that oil and natural gas company Hilcorp San Juan L.P. has agreed to pay $34.6 million to resolve allegations of violating the False Claim Act (FCA). According to the government, Hilcorp underpaid royalties to the Office of Natural Resources Revenue...

NJ Hospital and Investors Will Pay Over $30 Million to Resolve FCA Allegations

Jan 25, 2024 | False Claims Act

The DOJ just announced that Silver Lake Hospital and its investors will pay over $30,000,000 to resolve allegations of violating the False Claims Act (FCA) and the Federal Debt Collection Procedures Act (FDCPA). Silver Lake is a New Jersey based long-term care...

Home Health Care Company Will Pay Approximately $10 Million to Resolve Allegations of Violating the FCA

Jan 16, 2024 | False Claims Act

The DOJ announced Atlantic Home Health Care LLC (AHH) has agreed to pay $9,990,944 to resolve allegations of violating the False Claims Act (FCA). AHH’s former Corporate Administrator and Director of Human Resource Administration and Management, Tonya Cass, initially...

Ultragenyx Pharmaceutical Inc. Agrees to $6 Million Settlement to Resolve False Claims Allegations

Jan 16, 2024 | White Collar Crime

On December 21, the Department of Justice (DOJ) announced Ultragenyx Pharmaceutical Inc. reached a $6 million settlement to resolve allegations of violating the False Claims Act. The pharmaceutical company, based in California and specializing in rare disorders, faced...

Maryland Doctor’s COVID-19 Fraud Conviction Overturned

Jan 16, 2024 | White Collar Crime

On August 24, 2023, The Department of Justice announced the conviction of Ron Elfenbein, M.D., of Arnold, Maryland, for five counts of healthcare fraud. In a groundbreaking decision, Chief Judge James K. Bredar of the U.S. District Court for Maryland overturned the...

The Trademark Wars are Coming to Cannabis Beverages: Northern District of Illinois Denies Injunction for Alleged Infringement of FLORA Trademark.

Jan 3, 2024 | Trademark Enforcement, Trademark Protection

Shortly before Christmas, the Northern District of Illinois weighed in on what should be a growing area for trademark disputes in 2024 and beyond: the “hypercompetitive” market for cannabis-infused beverages. As the prevalence of CBD and THC-infused beverages,...
« Older Entries
Next Entries »

Recent Posts

  • Telehealth Company and Physician Owner Pay $300,000 To Resolve False Claims Act Liability Related to Excluded Provider
  • National Wound Care Provider Agrees to $45 Million False Claims Act Settlement
  • Knee Implant Manufacturer Agrees to $38.5 Million False Claims Act Settlement
  • CVS Pays $8.2 Million to Resolve False Claims Act Investigation
  • Congress Moves to Close “Hemp Loophole” in Shutdown Bill

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • Hemp & Cannabis
  • Hemp and Cannabis
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group